by Kylene Beers
First published 2021
Kylene Beers' "Generic and Innovator Drugs 8e" pulls back the curtain on the competitive pharmaceutical industry. As new drug patents expire, generic manufacturers rush to capture market share. But with billions in profits at stake, the battle between innovators and generics is fierce and cutthroat. Beers goes behind the scenes, revealing the intense negotiations, legal battles, and even underhanded tactics used to gain the upper hand. Readers will be shocked by the lengths companies will go to protect their turf. In the end, it's the consumers who pay the price - literally. This eye-opening exposé shows how the quest for profits can come at the expense of affordable healthcare.
Genres: medical, business, economics, non-fiction, health, academic
Vibes: intimate, suspenseful, thought-provoking
Tropes: expose, investigative-journalism
1704 pages · Loose Leaf · Wolters Kluwer Law & Business